Abstract: In one embodiment, a method for information management comprises monitoring output from an application, wherein the output is monitored substantially continuously; determining if the output is associated with a predetermined type of version; and saving data associated with the output if the output is associated with the predetermined type of version.

Abstract: An indication to allocate storage is received, where the storage is to be used to store previous version data associated with a protected data set. One or more storage groups are allocated of at least a prescribed allocation group size and comprising a set of physically contiguous storage locations.

Abstract: An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.

Abstract: An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.

Abstract: The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules.

Abstract: An indication to allocate storage is received, where the storage is to be used to store previous version data associated with a protected data set. One or more storage groups are allocated of at least a prescribed allocation group size and comprising a set of physically contiguous storage locations.

Abstract: In an embodiment of the invention, a technique for indexing data is disclosed. The technique comprises receiving packets; counting the received packets; determining whether there is a pattern associated with the received packets; and using a first algorithm if it is determined that there is a pattern.

Abstract: An indication to allocate storage is received, where the storage is to be used to store previous version data associated with a protected data set. One or more storage groups are allocated of at least a prescribed allocation group size and comprising a set of physically contiguous storage locations.

Abstract: Previous version data is copied to a location in a collection of snapshot data, wherein the collection of snapshot data represents a state of a protected data set at a baseline time associated with a snapshot. Once the previous version data has been copied to the location in the collection of snapshot data, an index is updated to associate the location in the collection of snapshot data with the previous version data. A data region storage location from which the previous version data was copied to the location in the collection of snapshot data is making available for reuse once the index has been updated.

Abstract: A low-calorie solid, pourable composition for emulating sugar, the composition comprising an intense sweetener and at least one low-calorie bulking agent selected from maltodextrin, magnesium oxide, magnesium carbonate, calcium stearate, colloidal silicon dioxide and starch or combinations thereof, and a process for the preparation of said composition.

Abstract: In some embodiments, a technique for processing a character comprises receiving a character; determining whether the character is in a predetermined language; transforming the character to a symbol associated with a private area of Unicode if it is determined that the character is not in the predetermined language; and storing a result of the transformation.

Abstract: A method for information management comprises monitoring output from an application to an operating system, wherein the output is monitored substantially continuously; determining if a policy applies to data associated with the output; and executing the policy if the policy applies.

Abstract: A method for information management comprises applying a software architecture for a first hardware configuration; applying the software architecture for a second hardware configuration; wherein the software architecture includes: monitoring an output from an application; distributing packets; and storing the packets.

Abstract: Information is managed by monitoring an output from an application. A change is intercepted. The change is associated with a file, if file versioning has been selected. The change is to a block, if block versioning has been selected. The change is saved.

Abstract: A method for information management comprises intercepting an output from an application; distributing packets according to a routing scheme, wherein the packets are associated with the output, and wherein distributing the packets may occur when the application is associated with a first operating system, and may also occur when the application is associated with a second operating system; and storing the packets.

Abstract: The extended release osmo-microsealed formulation includes three controlled release systems associated in series. First, there is an inner solid particulate phase containing Venlafaxine Hydrochloride (Active), and one or more hydrophobic polymers, one or more diluents required to increase the bulk one or more osmogen (agents which can generate osmotic pressure across the hydrophobic coating) and one or more binder polymers essentially to provide strength/hardness to the particle. Second, there is an outer solid continuous phase including one or more hydrophilic polymers, that is further compressed into a tablet. Third, there is an optional functional coat surrounding the tablet. The process/method for forming the Osmo-microsealed extended release delivery system and the process for using such system for treating human ailment/depression are also provided.

Abstract: A low-calorie solid, pourable composition for emulating sugar, the composition comprising an intense sweetener and at least one low-calorie bulking agent selected from maltodextrin, magnesium oxide, magnesium carbonate, calcium stearate, colloidal silicon dioxide and starch or combinations thereof, and a process for the preparation of said composition.

Abstract: An extended release pharmaceutical composition of Levetiracetam with once a day dosage regime and the process of preparing it. The extended release tablet of Levetiracetam is with the core comprising of Levetiracetam and water dispersible rate controlling polymer, and the tablet core is optionally functional coated comprising a combination of water non-dispersible and/or water dispersible polymer. It provides extended therapeutically effective plasma levels over a twenty four hour period with diminished incidences of neuropsychiatric adverse events by eliminating the troughs and peaks of drug concentration in a patients blood plasma, which comprises administering orally to a patient in need thereof, an extended release tablet that provides a peak blood plasma level of Levetiracetam in from about eight to about Sixteen hours. The core is prepared by Wet granulation, Dry granulation or Direct compression and optionally the tablet core is coated either in an coating pan or in and Fluidized bed system.

Abstract: In one embodiment, a method for information management comprises monitoring output from an application, wherein the output is monitored substantially continuously; determining if the output is associated with a predetermined type of version; and saving data associated with the output if the output is associated with the predetermined type of version.

Abstract: An extended release composition of Pramipexole or a pharmaceutical acceptable salt thereof, wherein the active agent is coated on a non pareil inert core, the drug loaded core is further coated with a polymeric layer which enables the release of the active agent over an extended period and optionally the extended release pellets being further blended with suitable excipients and compressed into a multi unit tablet and processes for the preparation of the said composition.